Status:
UNKNOWN
Prevalence of Non-alcoholic Fatty Liver Disease Among Non-obese Obstructive Sleep Apnea by Using Transient Elastography
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Sleep Apnea, Obstructive
Fatty Liver
Eligibility:
All Genders
18-65 years
Brief Summary
Obstructive sleep apnea (OSA) and non-alcoholic fatty liver disease (NAFLD) are both common diseases related to metabolic diseases with potential cardiovascular consequences and liver complications re...
Eligibility Criteria
Inclusion
- aged 18 years or more
Exclusion
- underlying cause of liver disease
- history of excessive alcoholic consumption (more than 30 g/day for men and 20 g/day for women)
- secondary causes of hepatic steatosis (such as chronic use of systemic corticosteroids)
- positive hepatitis B surface antigen, anti-hepatitis C virus antibody, or histological evidence of other concomitant chronic liver diseases.
Key Trial Info
Start Date :
April 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2025
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05351515
Start Date
April 30 2022
End Date
January 31 2025
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chinese University of Hong Kong
Hong Kong, Hong Kong